Page last updated: 2024-08-24

sertraline and Anxiety Neuroses

sertraline has been researched along with Anxiety Neuroses in 129 studies

Research

Studies (129)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	15 (11.63)	18.2507
2000's	51 (39.53)	29.6817
2010's	49 (37.98)	24.3611
2020's	14 (10.85)	2.80

Authors

Authors	Studies
Pu, B; Sun, B; Wang, C; Wang, N	1
Gasparyan, A; Manzanares, J; Navarrete, F; Navarro, D	1
Acierno, R; Allard, CB; Baker, AW; Luciano, MT; Martis, B; Norman, SB; Rauch, SAM; Simon, NM; Stein, MB; Szuhany, KL; Tuerk, PW	1
Simon, NM; Szuhany, KL	1
Batelaan, NM; Han, LKM; Hoogendoorn, AW; Hu, MX; Lever-van Milligen, BA; Penninx, BWJH; Révész, D; van Balkom, AJLM; van Oppen, P; van Schaik, DJF; Verhoeven, JE	1
Albano, AM; Birmaher, B; Cervin, M; Compton, SN; Gosch, E; Kendall, PC; Piacentini, J; Storch, EA; Walkup, JT	1
Albano, AM; Birmaher, B; Carper, MM; Compton, S; Ginsburg, GS; Gonzalez, A; Keeton, C; Kendall, PC; Langley, AK; Makover, HB; Olino, T; Peris, T; Piacentini, J; Sakolsky, D; Walkup, J	1
Ben Omar, N; Endres, K; Gaebler, AJ; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G	1
Coffey, BJ; Jaffe, RJ; McCoy, B	1
Albano, AM; Compton, S; Ginsburg, G; Keeton, C; Kendall, PC; McCracken, JT; Peris, TS; Piacentini, J; Rozenman, MS; Sakolsky, D; Sugar, CA; Walkup, JT	1
Hamill Skoch, S; Mills, JA; Ramsey, L; Strawn, JR	1
Albano, AM; Birmaher, B; Compton, SN; Crane, ME; Frank, HE; Ginsburg, GS; Keeton, C; Kendall, PC; Klugman, J; Norris, LA; Peris, TS; Piacentini, J; Sakolsky, D	1
Epperson, CN; Grillon, C; Hantsoo, L; Johnson, R; Marks, J; Sammel, M	1
Albano, AM; Birmaher, B; Compton, SN; Cornwall, GJ; Dobson, ET; Ginsburg, GS; Kendall, PC; McCracken, JT; Mills, JA; Piacentini, J; Rynn, MA; Sakolsky, D; Strawn, JR; Walkup, JT	1
Birmaher, B; Brodman, DM; Caporino, NE; Ginsburg, GS; Iyengar, S; Kendall, PC; McGuire, JF; Peris, TS; Piacentini, J; Sakolsky, D; Walkup, JT	1
Buszewicz, M; Cape, J; Clarke, CS; Kabir, T; Nazareth, I; Serfaty, M; Shafran, R; Tyrer, P	1
Albano, AM; Bergman, RL; Birmaher, B; Caporino, NE; Compton, SN; Ginsburg, GS; Kendall, PC; McCracken, JT; O'Rourke, S; Peris, TS; Piacentini, J; Sakolsky, D; Walkup, JT	1
Albano, AM; Becker-Haimes, EM; Compton, SN; Ginsburg, GS; Iyengar, S; Keeton, C; Kendall, PC; Peris, T; Piacentini, J; Sakolsky, D	1
Albano, AM; Birmaher, B; Compton, S; Ginsburg, G; Keeton, C; Kendall, PC; Olino, T; Peris, T; Piacentini, J; Sakolsky, D; Swan, AJ	1
Albano, AM; Birmaher, B; Comer, JS; Compton, SN; Coxe, S; Ginsburg, GS; Kendall, PC; Piacentini, J; Rynn, MA; Sakolsky, DJ; Sanchez, AL; Walkup, JT	1
Albano, AM; Birmaher, B; Compton, SN; Ginsburg, G; Gosch, E; Kendall, PC; Norris, LA; Olino, TM; Piacentini, J; Rifkin, LS; Walkup, J	1
Baldwin, DS; Chen, X; Fu, J; Fu, T; Gao, Z; Hou, R; Liu, Q; Liu, Y; Pan, M; Tang, Z; Ye, G; Zhu, F	1
Albano, AM; Birmaher, B; Caporino, NE; Compton, SN; Kendall, PC; Pérez, J; Peris, TS; Piacentini, J; Thamrin, H; Walkup, JT; Wu, MS	1
Alag, P; Balasubramaniam, M; Gupta, A; Gupta, S; Joshi, P; Maher, S; Tampi, D; Tampi, RR; Young, J	1
Ilias, I; Karaiskos, D; Liappas, I; Paparrigopoulos, T; Tzavellas, E	1
Albano, AM; Birmaher, B; Caporino, NE; Compton, SN; Cummings, CM; Ginsburg, G; Gosch, E; Keeton, C; Kendall, PC; March, J; McCracken, J; Piacentini, J; Read, KL; Rynn, M; Sakolsky, D; Settipani, CA; Sherrill, J; Walkup, JT	1
Mandrioli, R; Mercolini, L; Raggi, MA	1
Albano, AM; Birmaher, B; Caporino, NE; Compton, SN; Crawley, SA; Ginsburg, G; Gosch, E; Keeton, C; Kendall, PC; March, J; McCracken, J; Piacentini, J; Rynn, M; Sakolsky, D; Sherrill, J; Walkup, JT	1
Haddad, SA; Keshaviah, A; Pollack, MH; Simon, NM; Smoller, JW; Stein, MB; Van Ameringen, M	1
Albano, AM; Beidas, RS; Birmaher, B; Brodman, DM; Carper, M; Compton, SN; Cummings, C; Ginsburg, G; Keeton, CP; Kendall, PC; Lindhiem, O; March, J; McCracken, J; Piacentini, J; Rynn, M; Sakolsky, D; Sherrill, J; Swan, A; Walkup, J	1
Albano, AM; Almirall, D; Aschenbrand, SG; Birmaher, B; Compton, SN; Ginsburg, GS; Gosch, EA; Iyengar, S; Keeton, CP; Kendall, PC; March, JS; McCracken, JT; Peris, TS; Piacentini, JC; Rynn, MA; Sakolsky, D; Sherrill, J; Suveg, CM; Walkup, JT	1
Ryan, ND	1
Albano, AM; Bennett, S; Bergman, RL; Birmaher, B; Compton, SN; Ginsburg, G; Gosch, E; Iyengar, S; Kendall, PC; March, J; McCracken, J; Piacentini, J; Rynn, M; Sakolsky, D; Sherrill, J; Walkup, J; Waslick, B	1
Albano, AM; Birmaher, B; Compton, SN; Ginsburg, GS; Gonzalez, A; Keeton, CP; Kendall, PC; Kiff, CJ; March, J; McCracken, J; Peris, TS; Piacentini, J; Rynn, M; Sherrill, J; Vreeland, A; Walkup, JT	1
Davies, SJ; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM	1
Birmaher, B; Ginsburg, GS; Keeton, CP; Kendall, PC; Piacentini, J; Schleider, JL; Sherrill, J; Walkup, JT; Weisz, JR	1
Albano, AM; Becker, EM; Birmaher, BB; Compton, SN; Ginsburg, GS; Gordon-Hollingsworth, AT; Keeton, C; Kendall, PC; March, JS; Piacentini, J; Sakolsky, DJ; Suveg, CM	1
Ginsburg, G; Halldorsdottir, T; Kendall, PC; Ollendick, TH; Piacentini, J; Sakolsky, DJ; Sherrill, J; Walkup, J	1
Morrison, J; Schwartz, TL	1
Albano, AM; Almirall, D; Aschenbrand, S; Birmaher, B; Compton, SN; Ginsburg, G; Gosch, E; Iyengar, S; Keeton, CP; Kendall, PC; March, J; McCracken, JT; Peris, TS; Piacentini, J; Rynn, M; Sakolsky, D; Sherrill, J; Suveg, C; Walkup, JT	1
Akindipe, TO; Ipser, JC; Sager, C; Stein, DJ; Wilson, D	1
Eken, ZE; Kayhan, F; Uguz, F	1
Babovic, SS; Boskovic, K; Cvjetkovic-Bosnjak, M; Jovicevic, M; Soldatovic-Stajic, B	1
Albano, AM; Birmaher, B; Compton, S; Cummings, CM; Ginsburg, G; Gosch, E; Keeton, C; Kendall, PC; Narayanan, MK; Piacentini, J; Sherrill, J; Suveg, C; Treadwell, K; Villabø, MA; Walkup, J	1
Arkar, H; Bildik, T; Sevi Tok, ES	1
Cates, C; Norton, DJ	1
Gaynor, ST	1
Frazee, E; Leung, JG; Loomis, EA; Philbrick, KL	1
Albano, AM; Birmaher, B; Compton, SN; Ginsburg, GS; Iyengar, S; Kendall, PC; March, JS; McCracken, J; Piacentini, J; Rynn, MA; Sherrill, JT; Walkup, JT; Waslick, B	1
Emslie, GJ	1
Miller, MC	1
Arnow, BA; Barkin, JL; Dowling, F; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Rothbaum, BO; Trivedi, MH; Wisniewski, SR	1
Gale, CK; Millichamp, J	2
Braga, RJ; Rifkin, A	1
Hoffman, L	1
Birkett, DP	1
Bremner, JD; Vaccarino, V	1
Comijs, H; Emmelkamp, PM; Schuurmans, J; van den Hout, M; van Dyck, R; Weijnen, IJ	1
Azarpazhooh, MR; Hopwood, M; Khajehdaluee, M; Mokhber, N; Velayati, A	1
Batterham, PJ; Bennett, K; Christensen, H; Eagleson, C; Griffiths, KM; Guastella, AJ; Hickie, IB; Kalia, K; Kenardy, J; Mackinnon, AJ	1
Burgess, PM; Hollingworth, SA; Whiteford, HA	1
Boricević Marsanić, V; Kusmić, E	1
Kendall, T	1
Kamijima, K; Sheehan, DV	1
Hutcheon, ML	1
Albano, AM; Bergman, L; Birmaher, B; Coffey, KA; Compton, SN; Ginsburg, GS; Iyengar, S; Keeton, CP; Kendall, PC; March, J; McCracken, JT; Piacentini, J; Rynn, MA; Sakolsky, D; Sherrill, J; Walkup, JT	1
Almirall, D; Compton, SN; Duan, N; Gunlicks-Stoessel, M; Murphy, SA	1
Bergey, A; Rao, V; Rosenberg, P	1
Bondarenko, II; Kissin, MIa	1
Saldaña, SN; Strawn, JR	1
Maksimova, NM; Vertogradova, OP	1
Albano, AM; Birmaher, B; Brodman, DM; Caporino, NE; Compton, SN; Ginsburg, G; Gosch, E; Keeton, C; Kendall, PC; March, J; McCracken, J; Piacentini, J; Rynn, M; Sakolsky, D; Sherrill, J; Walkup, JT	1
Albano, AM; Birmaher, B; Drake, KL; Ginsburg, GS; Keeton, CP; Kendall, PC; March, JS; Piacentini, J; Rynn, M; Sakolsky, D; Walkup, JT	1
Stahl, SM	1
Ninan, PT	1
Kelsey, JE	1
Arnold, DH	1
Heerdink, ER; Leufkens, HG; Meijer, WE; van Eijk, JT	1
Rickels, K; Rynn, M	1
Emes, R; Gill, T; Khouzam, HR; Raroque, R	1
Boyer, P; Feiger, AD; Flament, MF; Gillespie, JA	1
Gorman, JM; Kent, JM; Kleber, M; Martinez, JM; Sullivan, GM; Yeragani, VK	1
Reiner, WG; Scharko, AM	1
Allgulander, C; Austin, C; Clary, CM; Dahl, AA; Fayyad, R; Kutcher, SP; Morris, PL; Sogaard, JA	1
Amsterdam, JD; Ruckenstein, MJ; Staab, JP	1
Ashton, AK	1
Allgulander, C; Austin, C; Burt, T; Kosar, H; Ravindran, A; Steiner, M	1
Ball, SG; Goddard, AW; Kuhn, A; Shekhar, A; Wall, D	1
Deveney, C; Hudson, JL; Taylor, L	1
Allgulander, C; Austin, C; Burt, T; Dahl, AA; Kutcher, SP; Ravindran, A	1
Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J	1
Clary, C; Endicott, J; Fayyad, R; Rapaport, MH	1
Günther, T; Herpertz-Dahlmann, B; Holtkamp, K; Jolles, J; Konrad, K	1
Maximova, NM; Misionzhnik, EY; Uzbekov, MG; Vertogradova, OP	1
Comijs, H; Emmelkamp, PM; Gundy, CM; Schuurmans, J; van den Hout, M; van Dyck, R; Weijnen, I	1
Davidson, JR	1
Bron, MS; Meng, F; Mullins, CD; Shaya, FT; Wang, J	1
Cohen, H; Kaplan, Z; Matar, MA; Zohar, J	1
Brawman-Mintzer, O; Carter, RE; Knapp, RG; Rickels, K; Rynn, M	1
Ahn, SC; Choi, TK; Lee, SH; Lee, YJ; Suh, SY; Yook, KH	1
Colombo, C; De Ronchi, D; Mandelli, L; Rossini, D; Serretti, A; Tarricone, I; Zanardi, R	1
Connor, K; Davidson, JR; Vaishnavi, S	1
Dupuy, JB; Ladouceur, R	1
Gorman, JM; Greenberg, HE; Klein, DF; Papp, LA; Rifkin, A; Scharf, SM; Weiss, JR	1
Finley, PR	1
Frost, L; Lal, S	1
Makela, EH; Sullivan, P; Taylor, M	1
Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF	1
Ajari, LJ; Lannon, RA; Louie, AK	1
Jackson, CW; Lydiard, RB; Morton, WA	1
Yonkers, KA	1
Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD	1
Bundren, JC; Warnock, JK	1
Sprenger, D	1
Brady, KT	1
Grimes, JB; Hines, A; Labbate, LA; Pollack, MH	1
Bouwer, C; Stein, DJ	1
Hensley, PL; Nurnberg, HG; Thompson, PM	1
DeVane, CL; Markowitz, JS	1
Davis, S; Friedman, ES; Harrison, W; Hirschfeld, RM; Keller, M; Koran, LM; Rush, J; Russell, JM	1
Ascher, JA; Batey, SR; Carmody, TJ; Donahue, RM; Metz, A; Rush, AJ	1
Brady, KT; McRae, AL	1
Brown, VL; Chrisman, AK; Compton, SN; Gammon, PJ; Grant, PJ; March, JS	1
Kashnikova, AA; Kim, LV; Koren', EV; Tatarova, IN; Voloshina, VM	1
Rickels, K; Rynn, MA; Siqueland, L	1
Bolden-Watson, C; Carmody, TJ; Donahue, RM; Houser, TL; Metz, A; Rush, AJ; Trivedi, MH	1

Reviews

17 review(s) available for sertraline and Anxiety Neuroses

Article	Year
Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies. Neuropharmacology, 2022, 11-01, Volume: 218 Topics: Animals; Anxiety Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic	2022
Anxiety Disorders: A Review. JAMA, 2022, 12-27, Volume: 328, Issue:24 Topics: Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Humans; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; United States; Venlafaxine Hydrochloride	2022
Antidepressants for anxiety disorders in late-life: A systematic review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2019, Volume: 31, Issue:4 Topics: Aged; Antidepressive Agents; Anxiety Disorders; Citalopram; Duloxetine Hydrochloride; Humans; Late Onset Disorders; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:11 Topics: Anxiety Disorders; Drug Evaluation, Preclinical; Half-Life; Humans; Phobic Disorders; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline	2013
Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants. International journal of emergency mental health, 2014, Volume: 16, Issue:1 Topics: Adolescent; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Brain; Depressive Disorder, Major; Feedback, Physiological; Female; Homicide; Humans; Neurons; Patient Admission; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Suicidal Ideation	2014
Pharmacotherapy for anxiety and comorbid alcohol use disorders. The Cochrane database of systematic reviews, 2015, Jan-20, Volume: 1 Topics: Alcohol-Related Disorders; Anxiety; Anxiety Disorders; Buspirone; Comorbidity; Desipramine; Humans; Paroxetine; Phobia, Social; Publication Bias; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic	2015
Generalised anxiety disorder. BMJ clinical evidence, 2007, Nov-20, Volume: 2007 Topics: Anxiety Disorders; Citalopram; Cognitive Behavioral Therapy; Double-Blind Method; Humans; Paroxetine; Remission Induction; Sertraline	2007
An evidence-based review of the clinical use of sertraline in mood and anxiety disorders. International clinical psychopharmacology, 2009, Volume: 24, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Child; Depression; Evidence-Based Medicine; Female; Humans; Male; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Generalised anxiety disorder. BMJ clinical evidence, 2011, Oct-27, Volume: 2011 Topics: Anxiety Disorders; Benzodiazepines; Buspirone; Humans; Hydroxyzine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline	2011
Pharmacotherapy of generalized anxiety disorder. The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 14 Topics: Algorithms; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Humans; Paroxetine; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2002
The antidepressant sertraline: a review of its uses in a range of psychiatric and medical conditions. Comprehensive therapy, 2003,Spring, Volume: 29, Issue:1 Topics: Antidepressive Agents; Anxiety Disorders; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fatigue Syndrome, Chronic; Feeding and Eating Disorders; Humans; Sertraline; Somatoform Disorders; Substance-Related Disorders	2003
Nature, assessment, and treatment of generalized anxiety disorder in children. Pediatric annals, 2005, Volume: 34, Issue:2 Topics: Anxiety Disorders; Child; Clinical Trials as Topic; Comorbidity; Fluvoxamine; Humans; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline	2005
Pharmacologic treatment of acute and chronic stress following trauma: 2006. The Journal of clinical psychiatry, 2006, Volume: 67 Suppl 2 Topics: Algorithms; Anxiety Disorders; Comorbidity; Depressive Disorder; Disasters; Drug Administration Schedule; Humans; Internet; Paroxetine; Psychotropic Drugs; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Survivors; Treatment Outcome	2006
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12 Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 3 Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles	1997
Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 9 Topics: 1-Naphthylamine; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Dissociative Disorders; Humans; Mental Disorders; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Stress Disorders, Post-Traumatic; Substance-Related Disorders	1997
Review of sertraline and its clinical applications in psychiatric disorders. Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:5 Topics: Antidepressive Agents; Anxiety Disorders; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance-Related Disorders	2001

Trials

48 trial(s) available for sertraline and Anxiety Neuroses

Article	Year
The influence of posttraumatic stress disorder treatment on anxiety sensitivity: Impact of prolonged exposure, sertraline, and their combination. Journal of traumatic stress, 2023, Volume: 36, Issue:1 Topics: Anxiety; Anxiety Disorders; Female; Humans; Implosive Therapy; Male; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans	2023
Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders. Journal of affective disorders, 2023, 05-15, Volume: 329 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Female; Hand Strength; Humans; Male; Sertraline	2023
Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders. Journal of child psychology and psychiatry, and allied disciplines, 2020, Volume: 61, Issue:4 Topics: Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELS. Journal of consulting and clinical psychology, 2021, Volume: 89, Issue:2 Topics: Adaptation, Psychological; Adolescent; Anxiety Disorders; Caregivers; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Longitudinal Studies; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2021
Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. Journal of child and adolescent psychopharmacology, 2017, Volume: 27, Issue:6 Topics: Adolescent; Anxiety Disorders; Bayes Theorem; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Placebo Effect; Selective Serotonin Reuptake Inhibitors; Sertraline	2017
Establishing Clinical Cutoffs for Response and Remission on the Screen for Child Anxiety Related Emotional Disorders (SCARED). Journal of the American Academy of Child and Adolescent Psychiatry, 2017, Volume: 56, Issue:8 Topics: Adolescent; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Drug Therapy, Combination; Female; Humans; Male; Outcome Assessment, Health Care; Phobia, Social; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline	2017
Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological Health technology assessment (Winchester, England), 2017, Volume: 21, Issue:45 Topics: Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Cost-Benefit Analysis; Female; Guideline Adherence; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2017
Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety. Journal of the American Academy of Child and Adolescent Psychiatry, 2017, Volume: 56, Issue:12 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Sertraline; Treatment Outcome	2017
Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes. Journal of consulting and clinical psychology, 2018, Volume: 86, Issue:9 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Longitudinal Studies; Male; Selective Serotonin Reuptake Inhibitors; Self Care; Sertraline; Treatment Outcome; Young Adult	2018
The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders. Journal of abnormal child psychology, 2020, Volume: 48, Issue:1 Topics: Adolescent; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Implosive Therapy; Male; Outcome and Process Assessment, Health Care; Patient Compliance; Phobia, Social; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline	2020
Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus. International journal of clinical practice, 2013, Volume: 67, Issue:3 Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Middle Aged; Pilot Projects; Self Care; Sertraline; Treatment Outcome; Young Adult	2013
The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. Journal of consulting and clinical psychology, 2013, Volume: 81, Issue:5 Topics: Adolescent; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Phobic Disorders; Placebos; Professional-Patient Relations; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2013
Somatic complaints in anxious youth. Child psychiatry and human development, 2014, Volume: 45, Issue:4 Topics: Adaptation, Psychological; Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Health Status; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Symptom Assessment; Treatment Outcome	2014
Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:6 Topics: Adult; Anxiety Disorders; Biomarkers, Pharmacological; Female; Genotyping Techniques; Humans; Male; Multivariate Analysis; Norepinephrine Plasma Membrane Transport Proteins; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Remission Induction; RGS Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome	2014
Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. Journal of consulting and clinical psychology, 2014, Volume: 82, Issue:2 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Socioeconomic Factors; Treatment Outcome	2014
24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). Journal of the American Academy of Child and Adolescent Psychiatry, 2014, Volume: 53, Issue:3 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2014
Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study. Comprehensive psychiatry, 2014, Volume: 55, Issue:5 Topics: Antidepressive Agents; Antipsychotic Agents; Anxiety; Anxiety Disorders; Benzodiazepines; Depressive Disorder, Major; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2014
Parental psychopathology and treatment outcome for anxious youth: roles of family functioning and caregiver strain. Journal of consulting and clinical psychology, 2015, Volume: 83, Issue:1 Topics: Adolescent; Animals; Antidepressive Agents; Anxiety Disorders; Caregivers; Child; Child of Impaired Parents; Cognitive Behavioral Therapy; Family; Female; Humans; Male; Mental Disorders; Parents; Self Report; Sertraline; Stress, Psychological; Treatment Outcome	2015
Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes. Child psychiatry and human development, 2015, Volume: 46, Issue:5 Topics: Adolescent; Anxiety Disorders; Anxiety, Separation; Black or African American; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Phobic Disorders; Psychotherapeutic Processes; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; White People	2015
Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS. Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 2015, Volume: 44, Issue:6 Topics: Adolescent; Anxiety Disorders; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; Child; Cognitive Behavioral Therapy; Comorbidity; Female; Follow-Up Studies; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome	2015
Trajectories of change in youth anxiety during cognitive-behavior therapy. Journal of consulting and clinical psychology, 2015, Volume: 83, Issue:2 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Relaxation Therapy; Sertraline; Treatment Outcome	2015
Pregabalin versus sertraline in generalized anxiety disorder. An open label study. European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:11 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Pregabalin; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2015
Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study. Journal of consulting and clinical psychology, 2016, Volume: 84, Issue:1 Topics: Adaptation, Psychological; Adolescent; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Treatment Outcome	2016
[The Effectiveness of Cognitive Behavioral Therapy, Medication, or Combined Treatment For Child Hood Anxiety Disorders]. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2016,Summer, Volume: 27, Issue:2 Topics: Anti-Anxiety Agents; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Humans; Hydroxyzine; Male; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome	2016
Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. The New England journal of medicine, 2008, Dec-25, Volume: 359, Issue:26 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2008
Long-term effectiveness and prediction of treatment outcome in cognitive behavioral therapy and sertraline for late-life anxiety disorders. International psychogeriatrics, 2009, Volume: 21, Issue:6 Topics: Aged; Aged, 80 and over; Anxiety Disorders; Attitude to Health; Cognitive Behavioral Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurotic Disorders; Personality Inventory; Prognosis; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2009
Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. Psychiatry and clinical neurosciences, 2010, Volume: 64, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Patient Selection; Sertraline; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome	2010
Protocol for a randomised controlled trial investigating the effectiveness of an online e-health application compared to attention placebo or sertraline in the treatment of generalised anxiety disorder. Trials, 2010, Apr-30, Volume: 11 Topics: Adolescent; Adult; Anti-Anxiety Agents; Anxiety Disorders; Australia; Cognitive Behavioral Therapy; Female; Humans; Internet; Male; Placebo Effect; Research Design; Sertraline; Time Factors; Treatment Outcome; Young Adult	2010
Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. Journal of consulting and clinical psychology, 2011, Volume: 79, Issue:6 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2011
Sertraline for treatment of post-stroke anxiety. The Journal of neuropsychiatry and clinical neurosciences, 2012,Spring, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Anxiety Agents; Anxiety Disorders; Female; Humans; Male; Middle Aged; Pilot Projects; Sertraline; Stroke	2012
Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. Journal of the American Academy of Child and Adolescent Psychiatry, 2013, Volume: 52, Issue:1 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Personality Inventory; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Detection, Psychological; Surveys and Questionnaires	2013
Benefits of child-focused anxiety treatments for parents and family functioning. Depression and anxiety, 2013, Volume: 30, Issue:9 Topics: Adolescent; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Family Health; Female; Humans; Male; Parents; Patient-Centered Care; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2013
Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry research, 2004, Jan-30, Volume: 125, Issue:1 Topics: Adult; Anxiety Disorders; Electrocardiography; Female; Heart Rate; Humans; Hyperventilation; Long QT Syndrome; Male; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Efficacy of sertraline in a 12-week trial for generalized anxiety disorder. The American journal of psychiatry, 2004, Volume: 161, Issue:9 Topics: Adult; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Sweating; Treatment Outcome	2004
A prospective trial of sertraline for chronic subjective dizziness. The Laryngoscope, 2004, Volume: 114, Issue:9 Topics: Adult; Anxiety Disorders; Chronic Disease; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Stress, Psychological; Treatment Outcome	2004
Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Human psychopharmacology, 2005, Volume: 20, Issue:1 Topics: Antidepressive Agents; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Sertraline; Sex Factors; Time Factors; Treatment Outcome	2005
Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline. The Journal of clinical psychiatry, 2005, Volume: 66, Issue:1 Topics: Adult; Anxiety Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2005
Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors. Acta psychiatrica Scandinavica, 2005, Volume: 111, Issue:6 Topics: Adult; Anxiety Disorders; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Somatoform Disorders; Surveys and Questionnaires	2005
The influence of sertraline on attention and verbal memory in children and adolescents with anxiety disorders. Journal of child and adolescent psychopharmacology, 2005, Volume: 15, Issue:4 Topics: Adolescent; Anxiety Disorders; Attention; Child; Female; Humans; Male; Memory; Mental Recall; Psychiatric Status Rating Scales; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline; Verbal Learning	2005
A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:3 Topics: Aged; Agoraphobia; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Female; Humans; Male; Middle Aged; Panic Disorder; Patient Dropouts; Personality Inventory; Reference Values; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Treatment Outcome; Waiting Lists	2006
Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry, 2006, Volume: 67, Issue:6 Topics: Adult; Anxiety Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2006
Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. Journal of psychosomatic research, 2007, Volume: 62, Issue:2 Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Fluvoxamine; Humans; Meditation; Paroxetine; Program Development; Self Care; Sertraline; Stress, Psychological; Surveys and Questionnaires	2007
Childhood psychopathology retrospectively assessed among adults with early onset major depression. Journal of affective disorders, 1994, Volume: 31, Issue:3 Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	1994
Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:9 Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Medical Records; Mental Disorders; Middle Aged; Mood Disorders; Paroxetine; Retrospective Studies; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1999
Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression. Depression and anxiety, 2001, Volume: 13, Issue:1 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Anxiety Disorders; Chronic Disease; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome	2001
Does pretreatment anxiety predict response to either bupropion SR or sertraline? Journal of affective disorders, 2001, Volume: 64, Issue:1 Topics: Antidepressive Agents; Anxiety Disorders; Buspirone; Delayed-Action Preparations; Double-Blind Method; Humans; Prognosis; Retrospective Studies; Sertraline; Surveys and Questionnaires; Treatment Outcome	2001
Sertraline in children and adolescents with social anxiety disorder: an open trial. Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:5 Topics: Adolescent; Antidepressive Agents; Anxiety Disorders; Child; Drug Administration Schedule; Female; Humans; Male; Sertraline; Social Adjustment; Treatment Outcome	2001
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American journal of psychiatry, 2001, Volume: 158, Issue:12 Topics: Adolescent; Anxiety Disorders; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Personality Assessment; Sertraline	2001

Other Studies

64 other study(ies) available for sertraline and Anxiety Neuroses

Article	Year
Clinical observation on the benefits of antidepressant intervention in advanced cancer patients. Medicine, 2022, Jul-01, Volume: 101, Issue:26 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Humans; Neoplasms; Sertraline	2022
Mediators of youth anxiety outcomes 3 to 12 years after treatment. Journal of anxiety disorders, 2020, Volume: 70 Topics: Adaptation, Psychological; Adolescent; Anxiety; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2020
Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders. British journal of clinical pharmacology, 2021, Volume: 87, Issue:3 Topics: Anxiety Disorders; Depression; Dipyrone; Humans; Ibuprofen; Pain, Postoperative; Selective Serotonin Reuptake Inhibitors; Sertraline	2021
Regaining Control: Anxiety in Sickle Cell Disease. Journal of child and adolescent psychopharmacology, 2020, Volume: 30, Issue:9 Topics: Adolescent; Anemia, Sickle Cell; Antidepressive Agents; Antisickling Agents; Anxiety Disorders; Chronic Pain; Depression; Female; Humans; Hydroxyurea; Self-Injurious Behavior; Sertraline	2020
Long-term Service Use Among Youths Previously Treated for Anxiety Disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2021, Volume: 60, Issue:4 Topics: Adolescent; Adult; Anxiety; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Female; Humans; Male; Sertraline; Treatment Outcome	2021
Journal of child and adolescent psychopharmacology, 2021, Volume: 31, Issue:5 Topics: Adolescent; Anxiety Disorders; Fluoxetine; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders	2021
Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder. Psychopharmacology, 2021, Volume: 238, Issue:10 Topics: Anxiety; Anxiety Disorders; Female; Humans; Menstrual Cycle; Premenstrual Dysphoric Disorder; Premenstrual Syndrome; Sertraline	2021
Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry, 2018, Volume: 57, Issue:7 Topics: Adolescent; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Longitudinal Studies; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Surveys and Questionnaires; Time Factors; Treatment Outcome	2018
The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination. Child psychiatry and human development, 2019, Volume: 50, Issue:6 Topics: Academic Performance; Adolescent; Anxiety Disorders; Child; Clinical Studies as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Outcome Assessment, Health Care; Parents; Patient Reported Outcome Measures; Schools; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2019
Multi-informant Expectancies and Treatment Outcomes for Anxiety in Youth. Child psychiatry and human development, 2019, Volume: 50, Issue:6 Topics: Adolescent; Anticipation, Psychological; Anxiety; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder. Brain, behavior, and immunity, 2019, Volume: 81 Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; C-Reactive Protein; Citalopram; Cohort Studies; Cytokines; Depression; Depressive Disorder; Female; Humans; Interleukin-12; Interleukin-6; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2019
A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. Behavior therapy, 2014, Volume: 45, Issue:1 Topics: Adolescent; Anti-Anxiety Agents; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Sertraline; Treatment Outcome	2014
Treating anxiety in youth: does maintenance treatment maintain? Journal of the American Academy of Child and Adolescent Psychiatry, 2014, Volume: 53, Issue:3 Topics: Anxiety Disorders; Cognitive Behavioral Therapy; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline	2014
Parental anxiety as a predictor of medication and CBT response for anxious youth. Child psychiatry and human development, 2015, Volume: 46, Issue:1 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Anxiety, Separation; Child; Child of Impaired Parents; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parents; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult	2015
Sertraline-induced periorbital purpura: a case report. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2015, Volume: 23, Issue:4 Topics: Adult; Anxiety Disorders; Female; Hemorrhage; Humans; Orbital Diseases; Purpura; Selective Serotonin Reuptake Inhibitors; Sertraline	2015
Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report. The primary care companion for CNS disorders, 2016, Volume: 18, Issue:3 Topics: Adult; Alopecia; Anxiety Disorders; Citalopram; Female; Humans; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline	2016
Temporal precedence in the identification of mediators of change: A brief comment on "Mediators of change in the child/adolescent multimodal treatment study" (Kendall et al., 2016). Journal of consulting and clinical psychology, 2017, Volume: 85, Issue:1 Topics: Adolescent; Anxiety; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Sertraline	2017
Rectal Bioavailability of Sertraline Tablets in a Critically Ill Patient With Bowel Compromise. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:3 Topics: Antidepressive Agents; Anxiety Disorders; Biological Availability; Critical Illness; Depressive Disorder; Female; Humans; Intestines; Middle Aged; Sertraline	2017
Pediatric anxiety--underrecognized and undertreated. The New England journal of medicine, 2008, Dec-25, Volume: 359, Issue:26 Topics: Adolescent; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2008
Treatment that works for anxious children. The Harvard mental health letter, 2009, Volume: 25, Issue:7 Topics: Adolescent; Antidepressive Agents; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Phobic Disorders; Randomized Controlled Trials as Topic; Sertraline	2009
Dealing with childhood anxiety. Child health alert, 2009, Volume: 27 Topics: Adaptation, Psychological; Adolescent; Anxiety Disorders; Child; Child Welfare; Cognitive Behavioral Therapy; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Early adversity in chronic depression: clinical correlates and response to pharmacotherapy. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adolescent; Adult; Age of Onset; Aged; Algorithms; Antidepressive Agents; Anxiety Disorders; Bupropion; Child; Child Abuse, Sexual; Chronic Disease; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Life Change Events; Male; Mianserin; Middle Aged; Mirtazapine; Parenting; Risk Factors; Self Concept; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult	2009
Behavioral therapy, sertraline, or both in childhood anxiety. The New England journal of medicine, 2009, Jun-04, Volume: 360, Issue:23 Topics: Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Placebos; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Behavioral therapy, sertraline, or both in childhood anxiety. The New England journal of medicine, 2009, Jun-04, Volume: 360, Issue:23 Topics: Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Behavioral therapy, sertraline, or both in childhood anxiety. The New England journal of medicine, 2009, Jun-04, Volume: 360, Issue:23 Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cognitive Behavioral Therapy; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Behavioral therapy, sertraline, or both in childhood anxiety. The New England journal of medicine, 2009, Jun-04, Volume: 360, Issue:23 Topics: Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline	2009
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use. The Australian and New Zealand journal of psychiatry, 2010, Volume: 44, Issue:6 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Australia; Citalopram; Cross-Sectional Studies; Depressive Disorder; Drug Utilization; Female; Health Surveys; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Statistical Distributions; Young Adult	2010
Menorrhagia and ecchymoses in an adolescent girl treated with sertaline. Archives of women's mental health, 2010, Volume: 13, Issue:5 Topics: Adolescent; Anxiety Disorders; Depressive Disorder; Drug Substitution; Ecchymosis; Female; Humans; Menorrhagia; Selective Serotonin Reuptake Inhibitors; Sertraline	2010
Generalised anxiety disorder. Recommendation on sertraline. BMJ (Clinical research ed.), 2011, Feb-22, Volume: 342 Topics: Antidepressive Agents; Anxiety Disorders; Humans; Sertraline	2011
An unexpected case of swollen optic nerves. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Anxiety Disorders; Child; Female; Humans; Papilledema; Pseudotumor Cerebri; Selective Serotonin Reuptake Inhibitors; Sertraline	2011
Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. Statistics in medicine, 2012, Jul-30, Volume: 31, Issue:17 Topics: Anxiety Disorders; Child; Cognitive Behavioral Therapy; Humans; Pilot Projects; Randomized Controlled Trials as Topic; Sertraline	2012
[Use of pregabalin and sertraline in complex treatment of patients with partial epilepsy comorbid with depressive and anxiety disorders]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:5 Topics: Adult; Anticonvulsants; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Male; Pregabalin; Sertraline; Treatment Outcome	2012
Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety. Journal of child and adolescent psychopharmacology, 2012, Volume: 22, Issue:6 Topics: Acetylcysteine; Adolescent; Antioxidants; Anxiety Disorders; Drug Therapy, Combination; Humans; Male; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2012
[The dynamics of anxious depression under the treatment with antidepressants with different mechanisms of action]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:11 Pt 2 Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazepines; Treatment Outcome; Young Adult	2012
Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorder. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Drug Therapy, Combination; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sertraline; Treatment Outcome	2002
Social anxiety disorder and the neurobiology of social relationships. Psychopharmacology bulletin, 2002,Winter, Volume: 36, Issue:1 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Male; Sertraline; Social Environment	2002
Social anxiety: an often silent disorder. Psychopharmacology bulletin, 2001,Autumn, Volume: 35, Issue:4 Topics: Antidepressive Agents; Anxiety Disorders; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Social Environment	2001
Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure. Pediatrics in review, 2002, Volume: 23, Issue:12 Topics: Adolescent; Amphetamine-Related Disorders; Antidepressive Agents; Antitussive Agents; Anxiety Disorders; Child; Dextromethorphan; Diagnosis, Differential; Drug Interactions; Female; Fluvoxamine; Hallucinogens; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; Obsessive-Compulsive Disorder; Seizures; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Syndrome; Sertraline	2002
Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands. Pharmacoepidemiology and drug safety, 2002, Volume: 11, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Child; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline	2002
Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies. International clinical psychopharmacology, 2003, Volume: 18, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	2003
Ssri-induced sexual dysfunction in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 2004, Volume: 43, Issue:9 Topics: Adolescent; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Cross-Sectional Studies; Depressive Disorder; Female; Hospitals, University; Humans; Male; Psychiatric Department, Hospital; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological	2004
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety. Consumer reports, 2004, Volume: 69, Issue:10 Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work	2004
Vardenafil reversal of female anorgasmia. The American journal of psychiatry, 2004, Volume: 161, Issue:11 Topics: Adult; Anxiety Disorders; Female; Humans; Imidazoles; Phosphodiesterase Inhibitors; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Sulfones; Treatment Outcome; Triazines; Vardenafil Dihydrochloride	2004
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram. Pharmacotherapy, 2005, Volume: 25, Issue:5 Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic	2005
Quality-of-life impairment in depressive and anxiety disorders. The American journal of psychiatry, 2005, Volume: 162, Issue:6 Topics: Adult; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Male; Personal Satisfaction; Quality of Life; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires	2005
Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action. Human psychopharmacology, 2006, Volume: 21, Issue:2 Topics: Adolescent; Adult; Amine Oxidase (Copper-Containing); Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Selective Serotonin Reuptake Inhibitors; Sertraline; Serum Albumin; Thiazepines	2006
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram. Clinical therapeutics, 2006, Volume: 28, Issue:2 Topics: Adolescent; Adult; Anxiety Disorders; Citalopram; Cohort Studies; Cost Sharing; Databases, Factual; Depression; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States	2006
The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:12 Topics: Animals; Anxiety Disorders; Avoidance Learning; Behavior, Animal; Behavioral Symptoms; Brain; Disease Models, Animal; Drug Administration Schedule; Male; Predatory Behavior; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Stress Disorders, Post-Traumatic; Stress, Psychological; Time Factors	2006
Antidepressant response in the elderly. Psychiatry research, 2007, Jul-30, Volume: 152, Issue:1 Topics: Adult; Age Factors; Aged; Antidepressive Agents; Anxiety Disorders; Bipolar Disorder; Cyclohexanols; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride	2007
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. Psychiatry research, 2007, Aug-30, Volume: 152, Issue:2-3 Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride	2007
Cognitive processes of generalized anxiety disorder in comorbid generalized anxiety disorder and major depressive disorder. Journal of anxiety disorders, 2008, Volume: 22, Issue:3 Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Attitude to Health; Cognition; Cognitive Behavioral Therapy; Comorbidity; Culture; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2008
Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders. The American journal of psychiatry, 1995, Volume: 152, Issue:10 Topics: 1-Naphthylamine; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Lung Diseases, Obstructive; Panic Disorder; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline	1995
Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. The American journal of psychiatry, 1995, Volume: 152, Issue:5 Topics: 1-Naphthylamine; Adult; Anxiety Disorders; Electric Injuries; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Substance Withdrawal Syndrome	1995
Sertraline and speech blockage. Journal of clinical psychopharmacology, 1994, Volume: 14, Issue:6 Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Dysarthria; Humans; Male; Sertraline; Verbal Behavior	1994
Withdrawal reaction after sertraline discontinuation. The American journal of psychiatry, 1994, Volume: 151, Issue:3 Topics: 1-Naphthylamine; Anxiety Disorders; Female; Half-Life; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	1994
Pharmacologic management of obsessive-compulsive disorder. Southern medical journal, 1994, Volume: 87, Issue:3 Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone	1994
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4 Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1997
Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy. Psychopharmacology bulletin, 1997, Volume: 33, Issue:2 Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antineoplastic Agents, Hormonal; Anxiety Disorders; Depressive Disorder; Endometriosis; Female; Humans; Leuprolide; Sertraline	1997
Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:5 Topics: 1-Naphthylamine; Adult; Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Buspirone; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome	1997
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997, Volume: 9, Issue:4 Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome	1997
Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy. The Journal of nervous and mental disease, 1998, Volume: 186, Issue:5 Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; South Africa; Survivors; Torture; Treatment Outcome	1998
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline. Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:1 Topics: Adult; Antibiotics, Antitubercular; Anxiety Disorders; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Male; Rifampin; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome	2000
[Sertraline in child and adolescent psychiatry]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2001, Volume: 101, Issue:8 Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires	2001
Do bupropion SR and sertraline differ in their effects on anxiety in depressed patients? The Journal of clinical psychiatry, 2001, Volume: 62, Issue:10 Topics: Adult; Anxiety Disorders; Bupropion; Comorbidity; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Inventory; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Treatment Outcome	2001